Dabur India expects double-digit consolidated revenue growth for the quarter ending September 30, 2026, driven by demand in Home and Personal Care. Despite geopolitical headwinds in the Middle East and ongoing commodity inflation, the company continues to see strong performance in its core portfolios. Official financial results are scheduled for release on November 4, 2026.
Dabur India has provided an update on its business performance for the quarter ending September 30, 2026, forecasting double-digit consolidated revenue growth. This projection indicates sustained momentum in its domestic FMCG portfolio, even as the company manages complex operating challenges including regional geopolitical tensions and persistent commodity inflation.
The Home and Personal Care division remains a key contributor to this growth, with specific categories such as hair oils and shampoos expected to deliver high-teens growth for the fourth consecutive quarter. The company noted that while its international business faces pressure from instability in the Middle East, it still anticipates high-teens growth in rupee terms. Operations in markets including Egypt, Turkey, the United Kingdom, and the United States have continued to support this international performance.
From a distribution standpoint, Dabur is seeing a shift in consumer buying patterns. Newer channels like quick commerce and e-commerce are reporting significant growth, while traditional trade remains steady, particularly in rural markets. The company’s omnichannel strategy is aimed at capturing demand across both urban and rural geographies.
While the revenue outlook is positive, profit margins remain a point of focus. The company has faced pressure on operating margins due to high input costs across its Home and Personal Care and healthcare segments. To manage these costs, Dabur has employed strategies such as calibrated price increases and cost-optimization programs.
In corporate developments, the company recently received approval from the National Company Law Tribunal for its merger with Sesa Care. The merger has an appointed date of April 1, 2026, and is part of the company's efforts to streamline its portfolio.
Investors should note that the company’s trading window is currently closed, effective from October 1, 2026, through November 6, 2026, in compliance with standard reporting protocols. The official financial results for the second quarter of the 2026-27 fiscal year are scheduled for announcement on November 4, 2026. The ability to maintain profitability amidst ongoing inflationary pressures and global geopolitical headwinds will be a primary focus for observers when the final numbers are released.